Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Kristoffer Jarlov Jensen

Biographic Data

ID9802027
NAMEKristoffer Jarlov Jensen
GIVEN NAMESKristoffer Jarlov
FAMILY NAMEJensen
SIGNATUREJENSEN K J
AFFILIATIONSUniversity of Southern Denmark
ORCID0000-0001-9687-5706
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2020
H-INDEX0
  • Seasonal variation in the non-specific effects of BCG vaccination on neonatal mortality

    Open Access•Kristoffer Jarlov Jensen, Sofie Biering-Sørensen et al.•ARTICLE•BMJ Global Health•2020

    The BCG vaccine protects non-specifically against other diseases than tuberculosis. Three randomised controlled trials of early BCG in Guinea-Bissau found a 38% reduction in all-cause neonatal mortality. Little is known about the underlying mechanisms. In Guinea-Bissau, prevalent infectious diseases display distinct seasonality. Revisiting the three trials (>6500 infants) comparing early BCG versus no early BCG in low weight infants on all-cause …

  • BCG skin reactions by 2 months of age are associated with better survival in infancy

    Open Access•Frederik Schaltz‐Buchholzer, Mike Berendsen et al.•ARTICLE•BMJ Global Health•2020

    INTRODUCTION: Receiving Bacille Calmette-Guérin (BCG)-Denmark vaccine at birth has been associated with ~40% reductions in all-cause neonatal mortality. We evaluated determinants of BCG skin reaction characteristics by age 2 months and tested the association with subsequent mortality. METHODS: Prospective observational study amalgamating five trials providing BCG-at-birth that were conducted between 2002 and 2018 in Guinea-Bissau. The reaction st…

No prominent works on this page.

  • Seasonal variation in the non-specific effects of BCG vaccination on neonatal mortality

    Open Access•Kristoffer Jarlov Jensen, Sofie Biering-Sørensen et al.•ARTICLE•BMJ Global Health•2020

    The BCG vaccine protects non-specifically against other diseases than tuberculosis. Three randomised controlled trials of early BCG in Guinea-Bissau found a 38% reduction in all-cause neonatal mortality. Little is known about the underlying mechanisms. In Guinea-Bissau, prevalent infectious diseases display distinct seasonality. Revisiting the three trials (>6500 infants) comparing early BCG versus no early BCG in low weight infants on all-cause …

  • BCG skin reactions by 2 months of age are associated with better survival in infancy

    Open Access•Frederik Schaltz‐Buchholzer, Mike Berendsen et al.•ARTICLE•BMJ Global Health•2020

    INTRODUCTION: Receiving Bacille Calmette-Guérin (BCG)-Denmark vaccine at birth has been associated with ~40% reductions in all-cause neonatal mortality. We evaluated determinants of BCG skin reaction characteristics by age 2 months and tested the association with subsequent mortality. METHODS: Prospective observational study amalgamating five trials providing BCG-at-birth that were conducted between 2002 and 2018 in Guinea-Bissau. The reaction st…

Environmental health (2 works) · History (2 works) · Immune responses and vaccinations (2 works) · Medicine (2 works) · New guinea (2 works) · Pediatrics (2 works) · BCG vaccine (1 work) · Child Nutrition and Water Access (1 work) · Demography (1 work) · Immunodeficiency and Autoimmune Disorders (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae